|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.58 USD | -6.82% |
|
+17.89% | +40.54% |
| Capitalization | 1.41TCr 1.9TCr 1.63TCr 1.49TCr 2.6TCr 1,78600Cr 2.66TCr 18TCr 6.9TCr 86TCr 7.15TCr 6.99TCr 3,03800Cr | P/E ratio 2026 * |
-19.8x | P/E ratio 2027 * | -19.5x |
|---|---|---|---|---|---|
| Enterprise value | 1.39TCr 1.88TCr 1.6TCr 1.47TCr 2.57TCr 1,76000Cr 2.62TCr 17TCr 6.8TCr 84TCr 7.04TCr 6.89TCr 2,99300Cr | EV / Sales 2026 * |
2,368x | EV / Sales 2027 * | 211x |
| Free-Float |
15.64% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Summit Therapeutics Inc.
| 1 day | -6.82% | ||
| 1 week | +17.89% | ||
| Current month | +29.64% | ||
| 1 month | +58.48% | ||
| 3 months | +45.88% | ||
| 6 months | +31.16% | ||
| Current year | +40.54% |
| 1 week | 21.26 |  | 29.23 |
| 1 month | 15.36 | | 29.23 |
| Current year | 13.83 | | 29.23 |
| 1 year | 13.83 | | 36.91 |
| 3 years | 1.3 | | 36.91 |
| 5 years | 0.66 | | 36.91 |
| 10 years | 0.66 | | 36.91 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 54 | 25/07/2022 |
Robert Duggan
CEO | Chief Executive Officer | 81 | 01/04/2020 |
| Director of Finance/CFO | 48 | 02/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Duggan
CHM | Chairman | 81 | 01/02/2020 |
Robert Booth
BRD | Director/Board Member | 72 | 28/09/2022 |
| Director/Board Member | 48 | 01/12/2019 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.82% | +17.89% | -2.54% | +1,465.61% | 2.05TCr | |
| -1.17% | -3.77% | +29.42% | +92.18% | 5.02TCr | |
| +0.71% | -6.85% | +84.17% | +29.89% | 4.36TCr | |
| +2.48% | -5.81% | +107.85% | +692.97% | 3.04TCr | |
| -2.69% | +10.35% | +6.67% | -8.18% | 2.82TCr | |
| -0.79% | -5.91% | +70.83% | -30.45% | 1.87TCr | |
| +1.77% | +8.27% | +79.99% | +251.29% | 1.73TCr | |
| +2.51% | -3.66% | +37.48% | -36.34% | 1.67TCr | |
| -1.46% | +1.65% | +72.81% | - | 1.49TCr | |
| +0.27% | +0.79% | +79.36% | +74.35% | 1.21TCr | |
| Average | -0.52% | +2.17% | +56.60% | +281.26% | 2.53TCr | |
| Weighted average by Cap. | -0.51% | +0.95% | +55.20% | +255.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 58.7L 79.25L 67.71L 62.19L 1.08Cr 74Cr 1.11Cr 7.3Cr 2.87Cr 36Cr 2.97Cr 2.91Cr 126.39Cr | 6.66Cr 8.98Cr 7.68Cr 7.05Cr 12Cr 842.61Cr 13Cr 83Cr 33Cr 403.68Cr 34Cr 33Cr 1.43TCr |
| Net income | -72Cr -97Cr -83Cr -76Cr -132.12Cr -9.06TCr -135.05Cr -890.91Cr -350.04Cr -4.34TCr -362.6Cr -354.96Cr -15TCr | -75Cr -101.53Cr -87Cr -80Cr -138.79Cr -9.52TCr -141.86Cr -935.84Cr -367.7Cr -4.56TCr -380.89Cr -372.86Cr -16TCr |
| Net Debt | -21Cr -28Cr -24Cr -22Cr -38Cr -2.63TCr -39Cr -258.64Cr -101.62Cr -1.26TCr -105.27Cr -103.05Cr -4.48TCr | -9.86Cr -13Cr -11Cr -10Cr -18Cr -1.25TCr -19Cr -122.68Cr -48Cr -598.03Cr -50Cr -49Cr -2.12TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/26/22 | 24.58 $ | -6.82% | 82,36,795 |
| 21/26/21 | 26.38 $ | +5.02% | 1,01,94,535 |
| 20/26/20 | 25.12 $ | -0.12% | 33,71,463 |
| 17/26/17 | 25.15 $ | +2.99% | 48,99,835 |
| 16/26/16 | 24.42 $ | +15.63% | 67,93,285 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SMMT Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition